RAD602
/ Radiopharm Theranostics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 17, 2023
Radiopharm Theranostics Enters Into Supply Agreement with TerThera for Terbium-161 Isotope
(GlobeNewswire)
- "Radiopharm Theranostics...is pleased to announce an agreement with TerThera to supply the Company with Terbium-161 (Tb-161)....Radiopharm will initiate a Phase I dose escalating trial of RAD 602 for treatment of patients with brain cancers during the fourth quarter of calendar 2023."
Licensing / partnership • New P1 trial • Brain Cancer • CNS Tumor • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1